Veterinary Vaccine Market - Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Merck, Zoetis, Merial/Sanofi, Boehringer Ingelheim

The veterinary vaccines market is anticipated to grow at a CAGR of 9.1% over the forecast period 2022 to 2027.

Veterinary Vaccine Market Overview

There are four kinds of Veterinary Vaccine, which are Live Attenuated Vaccines, Inactivated Vaccines, DNA Vaccines, and others; Live attenuated vaccines hold the largest share of the veterinary vaccines market, with a sales market share nearly 54.6% in 2016, the live attenuated vaccines segment is mainly driven by factors such as the increasing prevalence of diseases among porcine and poultry animals as well as the ease of administration and long-term immunity offered by these vaccines.Market competition is intense; Merck, Zoetis, Merial/Sanofi, Boehringer Ingelheim, etc. are the leader of the industry, and hold about 78% revenue market share, with high-end customers. They have formed global market channel of the industry. There are a lot of manufacturers in China, but the production quality is uneven.

When we consider the dependency of humans on animals, it is important that animal vaccines control the transmission of diseases which provides protection to animal and human health. Animals provide several important elements of human life such as food, milk, meat, protein along with commercial products like wool and leather. Some of the most common vaccines include foot & mouth diseases vaccines, equine influenza virus vaccines and rabies vaccines which help in preventing the transmission of infectious agents by creating natural immunity.

This particular market is anticipated to register a steady growth owing to increase in number of pets in developed countries and increasing number of poultry and cattle in developing countries. In addition, rise in investment for research and development of vaccines hinder the growth of antibiotic-resistant organisms boost the growth of animal vaccines market.

Industry News and Updates

10/27/2020: Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs-- 

Boehringer Ingelheim, a global leader in animal health, partnered with Henke-Sass, Wolf to develop an innovative intramuscular needle free vaccine injection tool for pigs around weaning until the end of nursery. This novel device will be available from December 2020 to swine producers in most countries globally under two different brands FreVAX™ (through Boehringer Ingelheim) and EPIG® (through Henke-Sass, Wolf).

02/27/2020: Zoetis Receives FDA Approval for Simparica Trio™, A New Combination Parasite Preventative for Dogs-- 

Zoetis today announced that the U.S. Food and Drug Administration (FDA) has approved Simparica TrioTM (sarolaner, moxidectin, and pyrantel chewable tablets), the first once-monthly, chewable tablet in the U.S. that delivers all-in-one protection from heartworm disease, ticks and fleas, roundworms and hookworms. This combination product builds on the trusted legacy of Simparica® (sarolaner) Chewables and exemplifies Zoetis’ dedication to innovation in parasiticides.

What are the major Applications, Types and Regions for Veterinary Vaccine Market?

Veterinary Vaccine Market is segmented based on the type, applications, companies and regions.

By Type, Veterinary Vaccine Market has been segmented into 

• Attenuated Vaccines


• Inactivated Vaccines


• Subunit Vaccines


• Toxoid Vaccines


• Conjugate Vaccines


• Recombinant Vaccines


• DNA Vaccines


• Other

By Application, Veterinary Vaccine Market has been segmented into

• 
  

  Application by Companion Animal

  
  
  
  
  
  • Dogs
  
  
  • Cats
  
  
  
  


• 
  

  Application by Livestock animal

  
  
  
  
  
  • Cattle
  
  
  • Pigs
  
  
  • Poultry
  
  
  • Sheep
  
  
  • Others
  
  
  
  


• 
  

  Application by Aquaculture

  
  

By Distribution Channel, Veterinary Vaccine Market has been segmented into

• Veterinary Hospitals


• Veterinary Clinics


• Pharmacies & Drug Stores


• Others

Veterinary Vaccine Market Segments Analysis

• Live attenuated segments are estimated to hold dominant market shares in the forecast period, despite their status as conventional products and the associated limitations. On the other hand, recombinant products are anticipated to grow at the highest CAGR due to their positive features such as purity, safety, efficacy, and potency.


• Companion Animal Segment to Exhibit Significant CAGR in the Near Future.


• The veterinary clinic segment accounted for the largest share because vaccinations are often a short-duration procedure that is often conducted at smaller institutions.

Veterinary Vaccine Market Regional Analysis:

The report offers in-depth assessment of the growth and other aspects of the Veterinary Vaccine Market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The largest market share belongs to North America. The Center for Veterinary Biologics (CVB) of the Animal and Plant Health Inspection Service regulates veterinary vaccinations in the United States (APHIS). The CVB grants animal health enterprises establishment and product licences to manufacture and sell veterinary biologics. Advances in vaccine development in the United States include the creation of live vector vaccines, non-replicating recombinant antigen vaccines, nucleic acid-mediated vaccinations, and live-gene-deleted vaccines. Vaccination of companion and wildlife animals against zoonotic diseases had a significant influence on reducing zoonotic disease occurrence. The need for veterinary vaccinations is predicted to rise in the region as people become more aware of disease prevention and technological improvements.

What is our Veterinary Vaccine Market report scope?

Key Takeaways from this Veterinary Vaccine Report

• Evaluate Veterinary Vaccine market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.


• Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.


• Analyze the sales and distribution channels across key geographies to improve top-line revenues.


• Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Veterinary Vaccine market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Veterinary Vaccine Market?

The Veterinary Vaccine Market is growing at a CAGR of 9.1% over the next 5 years.

Who are the key players in Veterinary Vaccine Market?

Merck, Zoetis, Merial/Sanofi, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco/Eli Lilly, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken, FATRO, Vaksindo, Bio-Labs, Avimex Animal, Hester Biosciences Limited, HIPRA

What are the significant types of Veterinary Vaccine Market?

Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines, Other

What are the major end-use applications of Veterinary Vaccine Market?

Application by Companion Animal, Application by Livestock animal, Application by Aquaculture

On the basis of type, Which segment is likely to hold the major share in the Veterinary Vaccine Market?

Attenuated Vaccines segment to hold the largest share in Veterinary Vaccine market

All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.